SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021)

SOPHiA GENETICS (SOPH) reported Raw Materials of $5.1 million for Q4 2021, up 57.17% on a YoY basis from $3.2 million in Q4 2020, and up 57.17% sequentially from $3.2 million in Q4 2020.

SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021) Analysis & Trends

SOPHiA GENETICS (SOPH) has 2 years of Raw Materials data on file, last reported at $5.1 million in Q4 2021.

  • For the quarter ending Q4 2021, Raw Materials rose 57.17% year-over-year to $5.1 million; the trailing twelve-month figure through Dec 2021 stood at $5.1 million (up 57.17% YoY), and the FY2021 full-year result was $5.1 million, up 57.17% from the prior year.
  • Raw Materials grew to $5.1 million in Q4 2021, from $3.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.1 million in Q4 2021 to a low of $3.2 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.59 Bn 24.28 Bn 662.02 Mn
2 BrightSpring Health Services 14.75 Bn 13.85 Bn 482.22 Mn
3 Healthequity 8.24 Bn 7.98 Bn 256.31 Mn
4 10x Genomics 5.91 Bn 5.37 Bn 106.18 Mn
5 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn
6 MiniMed 4.50 Bn 4.21 Bn 480.00 Mn
7 Waystar Holding 4.43 Bn 4.36 Bn 216.84 Mn
8 Doximity 3.91 Bn 3.16 Bn 125.97 Mn
9 Privia Health 3.19 Bn 2.77 Bn -
10 SOPHiA GENETICS 382.28 Mn 311.99 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 5.11 Mn
Dec 31, 2020 3.25 Mn